Cytosorbents (CTSO) Change in Accured Expenses (2010 - 2026)
Cytosorbents posted quarterly Change in Accured Expenses of $92000.0 for Q1 2026, up 125.07% year-on-year from $40876.5 in Q1 2025, and up 117.07% on a QoQ basis from -$539000.0 in Q4 2025.
Cytosorbents (CTSO) has 17 years of Change in Accured Expenses data on file, last reported at $92000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 125.07% year-over-year to $92000.0; the trailing twelve-month figure through Mar 2026 stood at -$247000.0 (up 72.35% YoY), and the FY2025 full-year result was -$706000.0, up 60.95% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $92000.0, up from -$539000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.4 million in Q4 2024 and bottomed at -$1.3 million in Q1 2024.
- The 5-year median for Change in Accured Expenses is -$338765.0 (2023), against an average of -$239036.0.
- The widest annual swing landed in 2022, when Change in Accured Expenses tumbled 490.9%; it then surged 371.1% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at -$206441.0 in 2022, then surged by 371.1% to $559666.0 in 2023, then soared by 142.64% to $1.4 million in 2024, then plunged by 139.69% to -$539000.0 in 2025, then jumped by 117.07% to $92000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $92000.0 (Q1 2026), -$539000.0 (Q4 2025), and $193000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 92,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | -539,000.00 |
| Dec 31, 2025 | -539,000.00 |
| Sep 30, 2025 | 193,000.00 |
| Sep 30, 2025 | 193,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | -367,000.00 |
| Mar 31, 2025 | -367,000.00 |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -750,276.00 |
| Jun 30, 2024 | -750,276.00 |
| Mar 31, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.28 Mn |
| Dec 31, 2023 | 559,666.00 |
| Dec 31, 2023 | 559,666.00 |
| Sep 30, 2023 | 756,632.00 |
| Sep 30, 2023 | 756,632.00 |
| Jun 30, 2023 | -338,765.00 |
| Jun 30, 2023 | -338,765.00 |
| Mar 31, 2023 | 629,833.00 |
| Mar 31, 2023 | 629,833.00 |
| Dec 31, 2022 | -206,441.00 |
| Dec 31, 2022 | -206,441.00 |
| Sep 30, 2022 | -756,412.00 |
| Sep 30, 2022 | -756,412.00 |
| Jun 30, 2022 | -1.08 Mn |
| Jun 30, 2022 | -1.08 Mn |
| Mar 31, 2022 | -1.20 Mn |
| Mar 31, 2022 | -1.20 Mn |
| Dec 31, 2021 | 2.13 Mn |
| Dec 31, 2021 | 2.13 Mn |
| Sep 30, 2021 | 193,506.00 |
| Sep 30, 2021 | 193,506.00 |
| Jun 30, 2021 | 474,622.00 |
| Jun 30, 2021 | 474,622.00 |
| Mar 31, 2021 | -367,557.00 |
| Mar 31, 2021 | -367,557.00 |
| Dec 31, 2020 | 1.62 Mn |
| Dec 31, 2020 | 1.62 Mn |
| Sep 30, 2020 | -909,820.00 |
| Sep 30, 2020 | -909,820.00 |
| Jun 30, 2020 | 1.45 Mn |
| Jun 30, 2020 | 1.45 Mn |
| Mar 31, 2020 | -1.06 Mn |
| Mar 31, 2020 | -1.06 Mn |
| Dec 31, 2019 | 1.83 Mn |
| Dec 31, 2019 | 1.83 Mn |
| Sep 30, 2019 | -250,381.00 |
| Sep 30, 2019 | -250,381.00 |
| Jun 30, 2019 | 908,685.00 |
| Jun 30, 2019 | 908,685.00 |
| Mar 31, 2019 | -1.06 Mn |
| Mar 31, 2019 | -1.06 Mn |
| Dec 31, 2018 | 1.44 Mn |
| Dec 31, 2018 | 1.44 Mn |
| Sep 30, 2018 | 633,506.00 |
| Sep 30, 2018 | 633,506.00 |
| Jun 30, 2018 | -636,599.00 |
| Jun 30, 2018 | -636,599.00 |
| Mar 31, 2018 | 272,604.00 |
| Mar 31, 2018 | 272,604.00 |
| Dec 31, 2017 | 617,848.00 |
| Dec 31, 2017 | 617,848.00 |
| Sep 30, 2017 | -665,991.00 |
| Sep 30, 2017 | -665,991.00 |
| Jun 30, 2017 | -77,886.00 |
| Jun 30, 2017 | -77,886.00 |
| Mar 31, 2017 | -42,074.00 |
| Mar 31, 2017 | -42,074.00 |
| Dec 31, 2016 | 769,378.00 |
| Dec 31, 2016 | 769,378.00 |
| Sep 30, 2016 | 151,935.00 |
| Sep 30, 2016 | 151,935.00 |
| Jun 30, 2016 | 499,579.00 |
| Jun 30, 2016 | 499,579.00 |
| Mar 31, 2016 | 211,240.00 |
| Mar 31, 2016 | 211,240.00 |
| Dec 31, 2015 | 123,594.00 |
| Dec 31, 2015 | 123,594.00 |
| Sep 30, 2015 | 153,593.00 |
| Sep 30, 2015 | 153,593.00 |
| Jun 30, 2015 | -76,856.00 |
| Jun 30, 2015 | -76,856.00 |
| Mar 31, 2015 | -283,500.00 |
| Mar 31, 2015 | -283,500.00 |
| Dec 31, 2014 | 606,953.00 |
| Dec 31, 2014 | 606,953.00 |
| Sep 30, 2014 | -213,826.00 |
| Sep 30, 2014 | -213,826.00 |
| Jun 30, 2014 | 345,062.00 |
| Jun 30, 2014 | 345,062.00 |
| Mar 31, 2014 | -240,736.00 |
| Mar 31, 2014 | -240,736.00 |
| Dec 31, 2013 | 79,759.00 |
| Dec 31, 2013 | 79,759.00 |
| Sep 30, 2013 | -123,439.00 |
| Sep 30, 2013 | -123,439.00 |
| Jun 30, 2013 | 198,463.00 |
| Jun 30, 2013 | 198,463.00 |
| Mar 31, 2013 | -36,035.00 |
| Mar 31, 2013 | -36,035.00 |
| Dec 31, 2012 | 63,834.00 |
| Dec 31, 2012 | 63,834.00 |
| Sep 30, 2012 | 23,533.00 |
| Sep 30, 2012 | 23,533.00 |
| Jun 30, 2012 | 17,406.00 |
| Jun 30, 2012 | 17,406.00 |
| Mar 31, 2012 | 43,175.00 |
| Mar 31, 2012 | 43,175.00 |
| Dec 31, 2011 | -110,143.00 |
| Dec 31, 2011 | -110,143.00 |
| Sep 30, 2011 | -34,831.00 |
| Sep 30, 2011 | -34,831.00 |
| Jun 30, 2011 | 67,893.00 |
| Jun 30, 2011 | 67,893.00 |
| Mar 31, 2011 | 46,375.00 |
| Mar 31, 2011 | 46,375.00 |
| Dec 31, 2010 | -6,815.00 |
| Dec 31, 2010 | -6,815.00 |
| Sep 30, 2010 | 114,316.00 |
| Sep 30, 2010 | 114,316.00 |